Literature DB >> 26679995

HIV-1 Vpr Protein Induces Proteasomal Degradation of Chromatin-associated Class I HDACs to Overcome Latent Infection of Macrophages.

Bizhan Romani1, Nima Shaykh Baygloo2, Mojtaba Hamidi-Fard3, Mohammad Reza Aghasadeghi4, Elham Allahbakhshi5.   

Abstract

Mechanisms underlying HIV-1 latency remain among the most crucial questions that need to be answered to adopt strategies for purging the latent viral reservoirs. Here we show that HIV-1 accessory protein Vpr induces depletion of class I HDACs, including HDAC1, 2, 3, and 8, to overcome latency in macrophages. We found that Vpr binds and depletes chromatin-associated class I HDACs through a VprBP-dependent mechanism, with HDAC3 as the most affected class I HDAC. De novo expression of Vpr in infected macrophages induced depletion of HDAC1 and 3 on the HIV-1 LTR that was associated with hyperacetylation of histones on the HIV-1 LTR. As a result of hyperacetylation of histones on HIV-1 promotor, the virus established an active promotor and this contributed to the acute infection of macrophages. Collectively, HIV-1 Vpr down-regulates class I HDACs on chromatin to counteract latent infections of macrophages.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  E3 ubiquitin ligase; HIV1 Vpr; histone deacetylase (HDAC); human immunodeficiency virus (HIV); infection; latency; macrophage; proteasome

Mesh:

Substances:

Year:  2015        PMID: 26679995      PMCID: PMC4742738          DOI: 10.1074/jbc.M115.689018

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

Review 1.  HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention.

Authors:  X-J Yang; E Seto
Journal:  Oncogene       Date:  2007-08-13       Impact factor: 9.867

2.  HIV-1 Vpr induces the K48-linked polyubiquitination and proteasomal degradation of target cellular proteins to activate ATR and promote G2 arrest.

Authors:  Jean-Philippe Belzile; Jonathan Richard; Nicole Rougeau; Yong Xiao; Eric A Cohen
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

3.  Short communication: activation of latent HIV type 1 gene expression by suberoylanilide hydroxamic acid (SAHA), an HDAC inhibitor approved for use to treat cutaneous T cell lymphoma.

Authors:  Leonard C Edelstein; Sophia Micheva-Viteva; Bradley D Phelan; Joseph P Dougherty
Journal:  AIDS Res Hum Retroviruses       Date:  2009-09       Impact factor: 2.205

4.  LINE-1 retrotransposable element DNA accumulates in HIV-1-infected cells.

Authors:  R Brad Jones; Haihan Song; Yang Xu; Keith E Garrison; Anton A Buzdin; Naveed Anwar; Diana V Hunter; Shariq Mujib; Vesna Mihajlovic; Eric Martin; Erika Lee; Monika Kuciak; Rui André Saraiva Raposo; Ardalan Bozorgzad; Duncan A Meiklejohn; Lishomwa C Ndhlovu; Douglas F Nixon; Mario A Ostrowski
Journal:  J Virol       Date:  2013-10-02       Impact factor: 5.103

5.  Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein.

Authors:  Kasia Hrecka; Caili Hao; Magda Gierszewska; Selene K Swanson; Malgorzata Kesik-Brodacka; Smita Srivastava; Laurence Florens; Michael P Washburn; Jacek Skowronski
Journal:  Nature       Date:  2011-06-29       Impact factor: 49.962

6.  The HIV1 protein Vpr acts to enhance constitutive DCAF1-dependent UNG2 turnover.

Authors:  Xiaoyun Wen; Laurieann Casey Klockow; Michael Nekorchuk; Hamayun J Sharifi; Carlos M C de Noronha
Journal:  PLoS One       Date:  2012-01-24       Impact factor: 3.240

7.  Selective HDAC inhibition for the disruption of latent HIV-1 infection.

Authors:  Kirston M Barton; Nancie M Archin; Kara S Keedy; Amy S Espeseth; Yan-ling Zhang; Jennifer Gale; Florence F Wagner; Edward B Holson; David M Margolis
Journal:  PLoS One       Date:  2014-08-19       Impact factor: 3.240

8.  Recruitment of a SAP18-HDAC1 complex into HIV-1 virions and its requirement for viral replication.

Authors:  Masha Sorin; Jennifer Cano; Supratik Das; Sheeba Mathew; Xuhong Wu; Kelvin P Davies; Xuanling Shi; S-W Grace Cheng; David Ott; Ganjam V Kalpana
Journal:  PLoS Pathog       Date:  2009-06-05       Impact factor: 6.823

9.  CRL4-DDB1-VPRBP ubiquitin ligase mediates the stress triggered proteolysis of Mcm10.

Authors:  Manpreet Kaur; Md Muntaz Khan; Ananya Kar; Aparna Sharma; Sandeep Saxena
Journal:  Nucleic Acids Res       Date:  2012-05-08       Impact factor: 16.971

10.  Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation.

Authors:  E Verdin; P Paras; C Van Lint
Journal:  EMBO J       Date:  1993-08       Impact factor: 11.598

View more
  21 in total

1.  Vpr Targets TET2 for Degradation by CRL4VprBP E3 Ligase to Sustain IL-6 Expression and Enhance HIV-1 Replication.

Authors:  Lei Lv; Qi Wang; Yanping Xu; Li-Chung Tsao; Tadashi Nakagawa; Haitao Guo; Lishan Su; Yue Xiong
Journal:  Mol Cell       Date:  2018-06-07       Impact factor: 17.970

Review 2.  Underlying mechanisms of HIV-1 latency.

Authors:  Bizhan Romani; Elham Allahbakhshi
Journal:  Virus Genes       Date:  2017-03-03       Impact factor: 2.332

3.  Porcine Deltacoronavirus Infection Cleaves HDAC2 to Attenuate Its Antiviral Activity.

Authors:  Zhuang Li; Puxian Fang; Panpan Duan; Jiyao Chen; Liurong Fang; Shaobo Xiao
Journal:  J Virol       Date:  2022-08-02       Impact factor: 6.549

4.  Quantitative Proteomic Approach Identifies Vpr Binding Protein as Novel Host Factor Supporting Influenza A Virus Infections in Human Cells.

Authors:  Anne Sadewasser; Katharina Paki; Katrin Eichelbaum; Boris Bogdanow; Sandra Saenger; Matthias Budt; Markus Lesch; Klaus-Peter Hinz; Andreas Herrmann; Thomas F Meyer; Alexander Karlas; Matthias Selbach; Thorsten Wolff
Journal:  Mol Cell Proteomics       Date:  2017-03-13       Impact factor: 5.911

5.  HIV-1 Vpr degrades the HLTF DNA translocase in T cells and macrophages.

Authors:  Hichem Lahouassa; Marie-Lise Blondot; Lise Chauveau; Ghina Chougui; Marina Morel; Marjorie Leduc; François Guillonneau; Bertha Cecilia Ramirez; Olivier Schwartz; Florence Margottin-Goguet
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-25       Impact factor: 11.205

6.  HIV-1 Vpr reactivates latent HIV-1 provirus by inducing depletion of class I HDACs on chromatin.

Authors:  Bizhan Romani; Razieh Kamali Jamil; Mojtaba Hamidi-Fard; Pooneh Rahimi; Seyed Bahman Momen; Mohammad Reza Aghasadeghi; Elham Allahbakhshi
Journal:  Sci Rep       Date:  2016-08-23       Impact factor: 4.379

Review 7.  Hijacking of the Ubiquitin/Proteasome Pathway by the HIV Auxiliary Proteins.

Authors:  Tanja Seissler; Roland Marquet; Jean-Christophe Paillart
Journal:  Viruses       Date:  2017-10-31       Impact factor: 5.048

Review 8.  The HIV-1 Vpr Protein: A Multifaceted Target for Therapeutic Intervention.

Authors:  María Eugenia González
Journal:  Int J Mol Sci       Date:  2017-01-10       Impact factor: 5.923

9.  HIV-1 Vpr Induces Widespread Transcriptomic Changes in CD4+ T Cells Early Postinfection.

Authors:  Hélène Bauby; Christopher C Ward; Reiner Schulz; Caroline Goujon; Michael H Malim; Rupert Hugh-White; Chad M Swanson
Journal:  mBio       Date:  2021-06-22       Impact factor: 7.786

10.  Antibody production by in vivo RNA transfection.

Authors:  Bizhan Romani; Amirarsalan Kavyanifard; Elham Allahbakhshi
Journal:  Sci Rep       Date:  2017-09-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.